Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
09/2010
09/08/2010EP1478624B1 Chemical compounds
09/08/2010EP1388340B1 Compositions for transmucosal administration containing coenzyme q as the active ingredient
09/08/2010EP1347787B2 Use of dexpanthenol in contact lens care compositions
09/08/2010EP1320531B1 Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
09/08/2010EP1263759B1 Azaindoles
09/08/2010CN1899603B Novel indications of mannan-binding lectin (MBL) in the treatment of immunocompromised individuals
09/08/2010CN1842341B Active fraction having anti-cancer and anti-metastic activity isolated from leaves and stems of ginseng
09/08/2010CN1659144B Quinoline and isoquinoline derivatives, a process for their production and their use as inflammation inhibitors
09/08/2010CN101827936A CDH3 peptide and medicinal agent comprising the same
09/08/2010CN101827863A Antibodies that bind IL-4 and/or IL-13 and their uses
09/08/2010CN101827841A (R)-4-(heteroaryl) phenylethyl derivatives and pharmaceutical compositions containing them
09/08/2010CN101827593A Isothiazolopyridinones useful for the treatment of (inter alia) cystic fibrosis
09/08/2010CN101822820A Stable protein formulations
09/08/2010CN101822770A Medicinal composition with anti-tumor effect and application thereof
09/08/2010CN101822746A Chinese medicinal composition with function of enhancing immunity and preparation method thereof
09/08/2010CN101822667A Medicine composition containing imidazole-5-carboxylic acid derivatives
09/08/2010CN101822646A Fexofenadine hydrochloride orally disintegrating tablet and preparation method thereof
09/08/2010CN101352365B Positioner for fixing micro organs
09/08/2010CN101311189B Antigen epitope for exciting protective immunity against tubercle bacillus of human body and uses thereof
09/08/2010CN101289499B Cyclic peptide with -Ile-Sta-Sta-Pro- residue segment and used as immunity inhibitor and synthetic process thereof
09/08/2010CN101289498B Cyclic peptide with -val-sta-leu- residue segment and used as immunity inhibitor and synthetic process thereof
09/08/2010CN101181514B Chinese medicine health products for improving sub-health status and boosting immune function
09/08/2010CN101143834B Polymorphism for N-(4-trifluoromethylphenyl)-2-cyano-3-hydroxycrotonamide sodium salt and preparation method thereof
09/08/2010CN101130544B Chemical synthesis method for epinastine
09/08/2010CN101015571B Chinese caterpillar fungus polysaccharide buccal tablets and its preparing process
09/07/2010US7790916 therapy of NF-kappaB mediated diseases; mitochondrial diseases; transplantation medicine
09/07/2010US7790858 Immunoadhesin comprising increased neonatal Fc receptor specificity for use in treatment and prevention of cell proliferative disorders
09/07/2010US7790738 Methods of treating and preventing AIDS using of COX-2 inhibitors
09/07/2010US7790736 Dipeptidyl peptidase inhibitors
09/07/2010US7790723 1-[3-(3-cyclopentyloxy-4-methoxyphenyl)-3,4,5,6-tetrahydropyridazin-1-yl]-1-[4-methyl-2-(1-oxypyridin-2-yl)thiazol-5-yl]methanone, used for inhibiting proliferation of lymphocytes in a host, and for the treatment of osteoporosis, tumors, cachexia, atherosclerosis, arthritis, multiple sclerosis, diabetes
09/07/2010US7790713 Inhibitors of interleukin-1β converting enzyme
09/07/2010US7790712 and Mitogen-Activated Protein Kinase-Activated Protein kinase-2 (MAPKAP-k2 inhibitors, used for preventing or treating diseases and pathological conditions involving inflammation such as chronic inflammatory disease
09/07/2010US7790704 3'-{N'-[1-(3,4-Dimethylphenyl)-3-methyl-5-oxo-1,5-dihydropyrazol-4-ylidene]hydrazino}-2'-hydroxybiphenyl-3-carboxylic acid; thrombocytopenia and megakaryocytopoiesis treatment
09/07/2010US7790376 PREFERENTIAL CLASSIFICATON BETWEEN CANCER CELLS; OBTAIN SAMPLE, MONITOR SAMPLE FOR PREFERENTIAL ENZYMATIC ACTIVITY, EVALUATE DIFFERENTIATED CELLS; for of detecting presence or absence or level of a polynucleotide sequence encoding heparanase in a biological sample
09/07/2010US7790189 Triple helical oligonucleotide comprising polysaccharide carrier and unmethylated CpG motif for use as DNA vaccine in treatment of infection and metabolic disorders
09/07/2010US7790168 Modulation of immunostimulatory activity of immunostimulatory oligonucleotide analogs by positional chemical changes
09/07/2010US7790166 Anti-CD40 antibodies capable of blocking B-cell activation
09/07/2010US7790165 Immunoglobulin specific to receptor protein DR5 for treatment of cancer, inflammatory or autoimmune diseases
09/07/2010US7790158 Using tumor necrosis factors specific immunoglobulins to treat rheumatoid arthritis, diabetes type I, multiple sclerosis, and inflammatory bowel diseases
09/07/2010US7790152 Monoclonal antibodies that preferntially bind to proteins having cytolysis and immunogenic activity
09/07/2010CA2493680C Condensed heterocyclic pyrazole derivatives as kinase inhibitors
09/07/2010CA2438854C Method of preparing non-hydrated fexofenadine hydrochloride and novel crystalline form obtainable by this method
09/07/2010CA2431188C Pharmaceutical compositions enhancing the immunogenicity of poorly immunogenic antigens
09/07/2010CA2375810C Beta2-adrenoceptor agonists
09/05/2010CA2665771A1 Method and kit for effecting screening and immunogenic treatment using crt and/or erp57 translocation
09/02/2010WO2010099444A2 Modified live aeromonas hydrophila vaccine for aquatic animals
09/02/2010WO2010099432A2 Recognition of cyp2e1 epitopes
09/02/2010WO2010099044A2 Treatment of immunosuppression-related disorders
09/02/2010WO2010098429A1 Immunologic adjuvant composition and use thereof
09/02/2010WO2010098344A1 Tricyclic pyrazolopyrimidine derivative
09/02/2010WO2010098265A1 Polymeric micelle containing proteasome inhibitor
09/02/2010WO2010098217A1 Immunopotentiating fermented food obtained from fructan-containing food
09/02/2010WO2010097597A1 Antibodies specifically directed to the soluble form of ctla-4
09/02/2010WO2010097395A1 Pyrazole derivatives used as ccr4 receptor antagonists
09/02/2010WO2010097371A1 Ceramide-analogous metabolites
09/02/2010WO2010097172A1 New tetrahydropyrazolo[3,4-c]isoquinolin-5-amine derivatives
09/02/2010WO2010097012A1 ANTI-CεmX ANTIBODIES CAPABLE OF BINDING TO HUMAN mIgE ON B LYMPHOCYTES
09/02/2010WO2010030757A3 Aminopyrimidine inhibitors of histamine receptors for the treatment of disease
09/02/2010WO2009131712A3 Regulatory b cells and their uses
09/02/2010WO2009108118A9 16 alpha, 17 alpha-acetal glucocorticosteroidal derivatives and their use
09/02/2010US20100222576 2-Oxo-1-pyrrolidine derivatives, processes for preparing them and their uses
09/02/2010US20100222424 Method of Screening Drug with the Use of 67 kDa Laminin Receptor and Drug Obtained Thereby
09/02/2010US20100222400 F1F0-ATPase Inhibitors and Related Methods
09/02/2010US20100222386 Substituted piperidines
09/02/2010US20100222366 Piperidine derivatives as modulators of chemokine receptor activity
09/02/2010US20100222363 Bicyclic Derivatives as P38 Inhibitors
09/02/2010US20100222358 Octahydro-pyrrolo[3,4-b]pyrrole derivatives
09/02/2010US20100222349 Quinoline derivatives used to treat inflammatory and allergic diseases
09/02/2010US20100222348 Quinolinone derivatives as parp inhibitors
09/02/2010US20100222332 Pyrazolo-pyrazines derivatives used as g protein inhibitors
09/02/2010US20100222331 New compounds
09/02/2010US20100222325 Inhibitors of Bruton's Tyrosine Kinase
09/02/2010US20100222314 Aqueous-based Pharmaceutical Composition
09/02/2010US20100222313 Pharmaceutical compositions-4
09/02/2010US20100222298 Spill resistant formulations containing clays
09/02/2010US20100222272 Pharmaceutical Compositions for the Treatment of TNF-Alpha Related Disorders
09/02/2010US20100222258 TNF antagonist and TNF inhibitor containing it as an effective ingredient
09/02/2010US20100221761 Measuring circulating therapeutic antibody, antigen and antigen/antibody complexes using elisa assays
09/02/2010US20100221720 Plant artificial chromosomes, uses thereof and methods of preparing plant artificial chromosomes
09/02/2010US20100221359 Solid Compositions Containing Combinations of Lactoferrin, Colostrm, and Citrus Pectin
09/02/2010US20100221358 Synthetic derivatives beta glycolipids and compositions thereof for the treatment of pathologic disorders
09/02/2010US20100221331 Pharmaceutical compositions comprising colloidal silicon dioxide
09/02/2010US20100221314 Microneedle Device
09/02/2010US20100221298 Novel galenical system for active transport, method for preparation and use
09/02/2010US20100221288 Novel streptococcus pneumoniae open reading frames encoding polypeptide antigens and uses thereof
09/02/2010US20100221287 Streptococcus pneumoniae Polynucleotides and Sequences
09/02/2010US20100221281 High molecular weight polysaccharide that binds and inhibits virus
09/02/2010US20100221275 Protection of an animal against pestivirus infection
09/02/2010US20100221274 Method of administering a thymosin alpha 1 peptide
09/02/2010US20100221273 Treatment of viral infections
09/02/2010US20100221272 Immunomodulatory compositions and methods for treating disease with modified host defense peptides
09/02/2010US20100221271 Nucleic Acid and Amino Acid Sequences, and Vaccine for the Control of Ectoparasite Infestations in Fish
09/02/2010US20100221269 Synthetic lipid a derivative
09/02/2010US20100221268 T cell immunomodulation by placenta cell preparations
09/02/2010US20100221265 Immune modulation via c-type lectin
09/02/2010US20100221261 Iap bir domain binding compounds
09/02/2010US20100221259 Nitrogen-containing heterocyclic compounds and medicinal use thereof
09/02/2010US20100221258 Method of treating a pathological syndrome and a pharmaceutical agent
09/02/2010US20100221241 Constrained hiv envelope-based immunogen that simultaneously presents receptor and coreceptor binding sites
09/02/2010US20100221226 Use of a Bifidobacterium Strain for Preparing a Composition for Preventing and/or Treating Allergic Manifestations
1 ... 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 ... 1172